Funding for this research was provided by:
ALS Therapy Alliance (ATA-2014-F-034)
Amyotrophic Lateral Sclerosis Association (20-DDC-497)
CONICYT PIA/BASAL (AFB 170005 CARE UC)
the Angel Fund for ALS Research
the Cellucci Fund for ALS Research
the Michael Rosenfeld Fund
National Institutes of Health (NS111990-01, R01 NS104022)
Received: 30 December 2020
Accepted: 23 February 2021
First Online: 16 March 2021
Ethics approval and consent to participate
: All protocols involving rodents were carried out according to the NIH, ARRIVE and ANID/CONICYT guidelines and were approved by the Ethical and Bio-security Committees of Andrés Bello University.
: Not applicable.
: The authors declare that they have no competing interests.